AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35222688 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous stem cell transplantation combined with modified VTD regimen (n = 25)
Number of subjects: 42
Study 35222688 — intervention group
Group type: COMPARATOR
Intervention: Improved VTD regimen (control group, n = 17)
Number of subjects: 42
Study 35222688 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous stem cell transplantation combined with modified VTD regimen
Number of subjects: 42
Study 35222688 — intervention group
Group type: COMPARATOR
Intervention: Improved VTD regimen (control group)
Number of subjects: 42
Study 35001953 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative mild hyperventilation (ETCO2 of 30-32 mmHg)
Number of subjects: 104
Study 35001953 — intervention group
Group type: COMPARATOR
Intervention: Conventional ventilation (ETCO2 of 35-40 mmHg)
Number of subjects: 104
Study 33892777 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 ?g lysergic acid diethylamide (LSD) orally every 3rd day for 6 weeks
Number of subjects: 80
Study 33892777 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 32658765 — intervention group
Group type: EXPERIMENTAL
Intervention: Sham CED activation
Number of subjects: 25
Study 32658765 — intervention group
Group type: COMPARATOR
Intervention: No sham activation
Number of subjects: 25
Study 36220067 — intervention group
Group type: EXPERIMENTAL
Intervention: Single metreleptin injection
Number of subjects: 32
Study 36220067 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified sham feeding (vagal stimulation)
Number of subjects: 32
Study 36220067 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 33739313 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Acupuncture (TA)
Number of subjects: 1123
Study 33739313 — intervention group
Group type: EXPERIMENTAL
Intervention: Electro-Acupuncture (EA)
Number of subjects: 1123
Study 33739313 — intervention group
Group type: EXPERIMENTAL
Intervention: TA&EA (merged)
Number of subjects: 1123
Study 33739313 — intervention group
Group type: COMPARATOR
Intervention: Sham Acupuncture
Number of subjects: 1123
Study 32157250 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity interval training (HIIT)
Number of subjects: 40
Study 35098587 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose loading
Number of subjects: 31
Study 35098587 — intervention group
Group type: COMPARATOR
Intervention: Placebo loading
Number of subjects: 31
Study 34281695 — intervention group
Group type: EXPERIMENTAL
Intervention: G-ALP (crossed screw fixation)
Number of subjects: 157
Study 34281695 — intervention group
Group type: COMPARATOR
Intervention: G-TRI (parallel screw fixation)
Number of subjects: 157
Study 36342143 — intervention group
Group type: EXPERIMENTAL
Intervention: Baxdrostat 2 mg
Number of subjects: 248
Study 36342143 — intervention group
Group type: EXPERIMENTAL
Intervention: Baxdrostat 1 mg
Number of subjects: 248
Study 36342143 — intervention group
Group type: EXPERIMENTAL
Intervention: Baxdrostat 0.5 mg
Number of subjects: 248
Study 36342143 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 248
Study 36342143 — intervention group
Group type: COMPARATOR
Intervention: Baxdrostat 2 mg vs Placebo
Number of subjects: 248
Study 36342143 — intervention group
Group type: COMPARATOR
Intervention: Baxdrostat 1 mg vs Placebo
Number of subjects: 248
Study 34176575 — intervention group
Group type: EXPERIMENTAL
Intervention: Senior WISE memory intervention
Number of subjects: 0
Study 34176575 — intervention group
Group type: COMPARATOR
Intervention: Health promotion group
Number of subjects: 0
Study 35236653 — intervention group
Group type: EXPERIMENTAL
Intervention: Gongning granules plus low-dose hormone therapy
Number of subjects: 164
Study 35236653 — intervention group
Group type: COMPARATOR
Intervention: Estrogen progesterone (control group)
Number of subjects: 164
Study 32889451 — intervention group
Group type: EXPERIMENTAL
Intervention: Episodic Future Thinking (EFT)
Number of subjects: 250
Study 32889451 — intervention group
Group type: COMPARATOR
Intervention: Control Episodic Thinking (CET)
Number of subjects: 250
Study 32187352 — intervention group
Group type: EXPERIMENTAL
Intervention: Aortic valve replacement
Number of subjects: 180
Study 32187352 — intervention group
Group type: COMPARATOR
Intervention: Watchful waiting strategy
Number of subjects: 180
Study 33992289 — intervention group
Group type: EXPERIMENTAL
Intervention: Dance intervention (performed semiweekly for 8 months)
Number of subjects: 112
Study 33248629 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal diet containing 300 mg/kg of medium-chain α-monoglycerides (MG)
Number of subjects: 252
Study 33248629 — intervention group
Group type: COMPARATOR
Intervention: Basal diet (Control group)
Number of subjects: 252
Study 34342547 — intervention group
Group type: EXPERIMENTAL
Intervention: Expander prosthesis (EP)
Number of subjects: 68
Study 34342547 — intervention group
Group type: EXPERIMENTAL
Intervention: DIEP flap
Number of subjects: 68
Study 34342547 — intervention group
Group type: EXPERIMENTAL
Intervention: Reconstructed breasts (both EP and DIEP)
Number of subjects: 68
Study 34342547 — intervention group
Group type: EXPERIMENTAL
Intervention: BREAST-Q questionnaire
Number of subjects: 68
Study 34342547 — intervention group
Group type: EXPERIMENTAL
Intervention: Objective results
Number of subjects: 68
Study 33508442 — intervention group
Group type: EXPERIMENTAL
Intervention: Acu-TENS
Number of subjects: 32
Study 32391740 — intervention group
Group type: EXPERIMENTAL
Intervention: Early and systematic integration of specialist palliative care (consultation with a PC physician every six to eight weeks)
Number of subjects: 126
Study 32391740 — intervention group
Group type: COMPARATOR
Intervention: Standard oncology care
Number of subjects: 126
Study 32391740 — intervention group
Group type: EXPERIMENTAL
Intervention: Early and systematic integration of specialist palliative care
Number of subjects: 126
Study 35288500 — intervention group
Group type: EXPERIMENTAL
Intervention: Blue-violet light-emitting diode (LED) irradiation
Number of subjects: 31
Study 35288500 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 31
Study 33884643 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led, community-based diabetes self management education and support program (6 sessions, supported by educational materials)
Number of subjects: 76
Study 33884643 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 76
Study 32316589 — intervention group
Group type: EXPERIMENTAL
Intervention: Nordic Walking (NW) training for 12 weeks, 3 times a week at 70% intensity
Number of subjects: 36
Study 32316589 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 36
Study 36329915 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behavioral therapy (CBT) delivered via videoconference, 14 sessions over 16 weeks.
Number of subjects: 60
Study 36329915 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group (no immediate treatment).
Number of subjects: 60
Study 36329915 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based CBT (treatment group).
Number of subjects: 60
Study 36329915 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group (after treatment).
Number of subjects: 60
Study 33175090 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic liability for increased prescription opioid use
Number of subjects: 737473
Study 33175090 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic liability for increased prescription opioid use (multivariable MR)
Number of subjects: 737473
Study 33175090 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic liability for MDD
Number of subjects: 737473
Study 32690503 — intervention group
Group type: EXPERIMENTAL
Intervention: Behaviour change physiotherapy intervention (six, 30 min weekly group-based exercise sessions preceded by a 30 min cognitive behaviour approach discussion group)
Number of subjects: 260
Study 32690503 — intervention group
Group type: COMPARATOR
Intervention: Usual rehabilitation (six, 30 min weekly group-based exercise sessions)
Number of subjects: 260
Study 32690503 — intervention group
Group type: EXPERIMENTAL
Intervention: Behaviour change physiotherapy intervention
Number of subjects: 260
Study 32690503 — intervention group
Group type: COMPARATOR
Intervention: Usual rehabilitation
Number of subjects: 260
Study 35955635 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-wave diathermy heat therapy
Number of subjects: 35
Study 35955635 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-leg interval exercise training
Number of subjects: 35
Study 35955635 — intervention group
Group type: COMPARATOR
Intervention: Sham therapy
Number of subjects: 35
Study 34948915 — intervention group
Group type: EXPERIMENTAL
Intervention: N95 respirators
Number of subjects: 68
Study 34948915 — intervention group
Group type: COMPARATOR
Intervention: Surgical masks
Number of subjects: 68
Study 35708106 — intervention group
Group type: EXPERIMENTAL
Intervention: LT4 administration 3 hours post-iftar
Number of subjects: 31
Study 35708106 — intervention group
Group type: EXPERIMENTAL
Intervention: LT4 administration 1 hour pre-suhoor
Number of subjects: 31
Study 35708106 — intervention group
Group type: COMPARATOR
Intervention: LT4 administration 30 minutes pre-iftar
Number of subjects: 31
Study 32744924 — intervention group
Group type: EXPERIMENTAL
Intervention: Full program based on module trainings
Number of subjects: 117
Study 32744924 — intervention group
Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 117
Study 36249792 — intervention group
Group type: EXPERIMENTAL
Intervention: Atovaquone 1500 mg BID
Number of subjects: 61
Study 36249792 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study 36249792 — intervention group
Group type: EXPERIMENTAL
Intervention: Atovaquone plus standard of care
Number of subjects: 61
Study 36249792 — intervention group
Group type: EXPERIMENTAL
Intervention: Atovaquone levels
Number of subjects: 61
Study 33150888 — intervention group
Group type: EXPERIMENTAL
Intervention: ZnV2‐xInxO4 (x = 0.25, 0.50, 1.00)
Number of subjects: 5
Study 33150888 — intervention group
Group type: EXPERIMENTAL
Intervention: ZnVInO4
Number of subjects: 5
Study 33150888 — intervention group
Group type: EXPERIMENTAL
Intervention: ZnVCrO4
Number of subjects: 5
Study 33150888 — intervention group
Group type: EXPERIMENTAL
Intervention: ZnVFeO4
Number of subjects: 5
Study 35105650 — intervention group
Group type: EXPERIMENTAL
Intervention: Cuff pressure of 45 cmH2O
Number of subjects: 800
Study 35105650 — intervention group
Group type: COMPARATOR
Intervention: Cuff pressure of 60 cmH2O
Number of subjects: 800
Study 33462988 — intervention group
Group type: EXPERIMENTAL
Intervention: Trazpiroben 10 mg
Number of subjects: 0
Study 33462988 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 36273651 — intervention group
Group type: COMPARATOR
Intervention: Adrenaline (0.2 mg, 2 mL, 1:10000)
Number of subjects: 130
Study 36273651 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic Acid (100 mg, 2 mL)
Number of subjects: 130
Study 33578359 — intervention group
Group type: EXPERIMENTAL
Intervention: NetballSmart Dynamic Warm-up (NSDW)
Number of subjects: 77
Study 33578359 — intervention group
Group type: EXPERIMENTAL
Intervention: Power warm-up (PWU)
Number of subjects: 77
Study 34218315 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly guidance on nutrition, physical activity, water intake, and health-promoting behaviors
Number of subjects: 27
Study 34218315 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 27
Study 34218315 — intervention group
Group type: EXPERIMENTAL
Intervention: Underhydration during pregnancy
Number of subjects: 27
Study 33577964 — intervention group
Group type: EXPERIMENTAL
Intervention: Ubiquinol (300 mg) every 12 h for up to 7 days
Number of subjects: 43
Study 33577964 — intervention group
Group type: COMPARATOR
Intervention: Placebo every 12 h for up to 7 days
Number of subjects: 43
Study 33577964 — intervention group
Group type: EXPERIMENTAL
Intervention: Ubiquinol (300 mg)
Number of subjects: 43
Study 33577964 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study 35986739 — intervention group
Group type: EXPERIMENTAL
Intervention: Piperacillin tazobactam combined with high-frequency chest-wall oscillation (HFCWO)
Number of subjects: 92
Study 35986739 — intervention group
Group type: COMPARATOR
Intervention: Control group (conventional treatment with oxygen, antibiotics, antispasmodics, antiasthmatic drugs, phlegmolytic drugs, and HFCWO)
Number of subjects: 92
Study 35986739 — intervention group
Group type: EXPERIMENTAL
Intervention: Piperacillin tazobactam combined with HFCWO
Number of subjects: 92
Study 35986739 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 92
Study 32929540 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronic acid (ZA)
Number of subjects: 6018
Study 32929540 — intervention group
Group type: EXPERIMENTAL
Intervention: Clodronate (CL)
Number of subjects: 6018
Study 32929540 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibandronate (IB)
Number of subjects: 6018
Study 32929540 — intervention group
Group type: EXPERIMENTAL
Intervention: All bisphosphonates
Number of subjects: 6018
Study 32929540 — intervention group
Group type: EXPERIMENTAL
Intervention: Dental health factors
Number of subjects: 6018
Study 33444396 — intervention group
Group type: EXPERIMENTAL
Intervention: FlowOx™ therapy plus nominal care
Number of subjects: 0
Study 33444396 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 0
Study 33377925 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate (50 mg/kg loading dose for 15 min, followed by 15 mg·kg-1·h-1 infusion)
Number of subjects: 120
Study 33377925 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 120
Study 34027993 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (infliximab plus thiopurines)
Number of subjects: 1437
Study 34027993 — intervention group
Group type: COMPARATOR
Intervention: Infliximab monotherapy
Number of subjects: 1437
Study 34027993 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 1437
Study 35450777 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthodontic patients
Number of subjects: 240
Study 35450777 — intervention group
Group type: COMPARATOR
Intervention: Dentists
Number of subjects: 240
Study 35450777 — intervention group
Group type: COMPARATOR
Intervention: Non-oral-related practitioners
Number of subjects: 240
Study 35450777 — intervention group
Group type: COMPARATOR
Intervention: Orthodontists
Number of subjects: 240
Study 35450777 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall observers
Number of subjects: 240
Study 36361426 — intervention group
Group type: EXPERIMENTAL
Intervention: Foot reflexology applied on specific areas of the feet for 10 consecutive days
Number of subjects: 17
Study 36361426 — intervention group
Group type: COMPARATOR
Intervention: Control group received information on foot care and health
Number of subjects: 17
Study 32011785 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy for 2 months
Number of subjects: 202
Study 32011785 — intervention group
Group type: COMPARATOR
Intervention: Stress management education (active control)
Number of subjects: 202
Study 35477371 — intervention group
Group type: EXPERIMENTAL
Intervention: CSM-based intervention program
Number of subjects: 78
Study 33773802 — intervention group
Group type: EXPERIMENTAL
Intervention: Video training materials
Number of subjects: 60
Study 33773802 — intervention group
Group type: COMPARATOR
Intervention: Written material (Control group)
Number of subjects: 60
Study 35296532 — intervention group
Group type: EXPERIMENTAL
Intervention: Certolizumab pegol (CZP) 200 mg every 2 weeks
Number of subjects: 317
Study 35296532 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 317
Study 32957983 — intervention group
Group type: EXPERIMENTAL
Intervention: ASV-V (ResMed® devices)
Number of subjects: 177
Study 32957983 — intervention group
Group type: EXPERIMENTAL
Intervention: ASV-F (Philips® devices)
Number of subjects: 177
Study 32957983 — intervention group
Group type: EXPERIMENTAL
Intervention: Auto-EPAP usage
Number of subjects: 177
Study 34311440 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine mouth rinse (85 mg of caffeine in 25-ml mouth rinse for 5 s every 5 min during exercise)
Number of subjects: 10
Study 34311440 — intervention group
Group type: COMPARATOR
Intervention: Control (water mouth rinse)
Number of subjects: 10
Study 32336266 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug trial with presumed superiority of new drug versus equipoise
Number of subjects: 1140
Study 32336266 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug trial funded by public sources
Number of subjects: 1140
Study 32336266 — intervention group
Group type: COMPARATOR
Intervention: Diagnostic study
Number of subjects: 1140
Study 32336266 — intervention group
Group type: COMPARATOR
Intervention: Drug trial with random treatment allocation
Number of subjects: 1140
Study 32336266 — intervention group
Group type: COMPARATOR
Intervention: Diagnostic study factors tested (common vs. rare disease, genetic vs. protein analysis, automatic vs. reporting on request)
Number of subjects: 1140
Study 34779272 — intervention group
Group type: EXPERIMENTAL
Intervention: Discharge platelet count (PC)
Number of subjects: 252
Study 34779272 — intervention group
Group type: EXPERIMENTAL
Intervention: Discharge mean platelet volume (MPV)
Number of subjects: 252
Study 34779272 — intervention group
Group type: EXPERIMENTAL
Intervention: In-hospital platelet count (PC) difference
Number of subjects: 252
Study 34779272 — intervention group
Group type: EXPERIMENTAL
Intervention: In-hospital PC decrease
Number of subjects: 252
Study 34526078 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex psychosocial intervention providing advice, information, and care on emotional, psycho-social, and communicative levels during and after the cancer experience
Number of subjects: 560
Study 34526078 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 560
Study 35611396 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant therapy (cisplatin and 5-fluorouracil chemotherapy plus radiotherapy)
Number of subjects: 96
Study 35611396 — intervention group
Group type: COMPARATOR
Intervention: Adjuvant therapy (cisplatin, 5-fluorouracil, and epirubicin chemotherapy with concurrent extended volume radiotherapy)
Number of subjects: 96
Study 35611396 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant therapy
Number of subjects: 96
Study 35611396 — intervention group
Group type: COMPARATOR
Intervention: Adjuvant therapy
Number of subjects: 96
Study 33248746 — intervention group
Group type: EXPERIMENTAL
Intervention: L4/5 zygapophyseal mobilizations
Number of subjects: 24
Study 33922493 — intervention group
Group type: EXPERIMENTAL
Intervention: Tart Cherry Concentrate (30 mL twice per day for 3 months)
Number of subjects: 50
Study 33922493 — intervention group
Group type: COMPARATOR
Intervention: Placebo (isocaloric, 30 mL twice per day for 3 months)
Number of subjects: 50
Study 34409935 — intervention group
Group type: EXPERIMENTAL
Intervention: Play2Sleep
Number of subjects: 63
Study 34409935 — intervention group
Group type: COMPARATOR
Intervention: Comparison home visit
Number of subjects: 63
Study 34600487 — intervention group
Group type: EXPERIMENTAL
Intervention: ERAS treatment
Number of subjects: 116
Study 34600487 — intervention group
Group type: COMPARATOR
Intervention: Traditional treatment (Control)
Number of subjects: 116
Study 33176512 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological interventions
Number of subjects: 0
Study 33176512 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle medicine interventions
Number of subjects: 0
Study 33176512 — intervention group
Group type: COMPARATOR
Intervention: Pharmacologic interventions
Number of subjects: 0
Study 33176512 — intervention group
Group type: COMPARATOR
Intervention: Complementary and alternative medicine (CAM)
Number of subjects: 0
Study 33267610 — intervention group
Group type: EXPERIMENTAL
Intervention: Invasive strategy
Number of subjects: 0
Study 33267610 — intervention group
Group type: COMPARATOR
Intervention: Type 1 MI
Number of subjects: 0
Study 32040761 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab
Number of subjects: 2
Study 32040761 — intervention group
Group type: COMPARATOR
Intervention: Anti-TNF agents
Number of subjects: 2
Study 35861797 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous Coronary Intervention (PCI) with everolimus‐eluting stents
Number of subjects: 1905
Study 35861797 — intervention group
Group type: COMPARATOR
Intervention: Coronary Artery Bypass Graft Surgery (CABG)
Number of subjects: 1905
Study 34364386 — intervention group
Group type: EXPERIMENTAL
Intervention: Booklet intervention delivered by general practitioner
Number of subjects: 1095
Study 34364386 — intervention group
Group type: EXPERIMENTAL
Intervention: Modification of antihypertensive treatment
Number of subjects: 1095
Study 34364386 — intervention group
Group type: EXPERIMENTAL
Intervention: Initiation of antihypertensive treatment
Number of subjects: 1095
Study 34364386 — intervention group
Group type: EXPERIMENTAL
Intervention: Booklet intervention
Number of subjects: 1095
Study 33091035 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast cancer awareness intervention (not specified in detail)
Number of subjects: 1758
Study 33091035 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical cancer awareness intervention (not specified in detail)
Number of subjects: 1758
Study 33091035 — intervention group
Group type: COMPARATOR
Intervention: Comparison of urban vs rural women in South Africa
Number of subjects: 1758
Study 33091035 — intervention group
Group type: COMPARATOR
Intervention: Comparison of married vs unmarried women in Uganda
Number of subjects: 1758
Study 35803849 — intervention group
Group type: EXPERIMENTAL
Intervention: Day-case LSG (DC LSG)
Number of subjects: 1544
Study 35803849 — intervention group
Group type: COMPARATOR
Intervention: Conventional hospitalization LSG (CH LSG)
Number of subjects: 1544
Study 33357122 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooling bandana
Number of subjects: 84
Study 33357122 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooling vest
Number of subjects: 84
Study 33357122 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooling bandana and cooling vest
Number of subjects: 84
Study 33357122 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 84
Study 35832107 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) stimulation at 2 Hz for 5 minutes
Number of subjects: 17